GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.211 | 27773936
|
EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.32 | 0.211 | 27783993
|
EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.32 | 0.211 | 25676692
|
EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.32 | 0.211 | 22194816
|
PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.7582 | 27773936
|
PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.32 | 0.7582 | 27783993
|
PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.32 | 0.7582 | 22194816
|
PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs | NA | 0.32 | 0.7582 | 25676692
|
ABCF1 | 70 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0011 | 31100412
|
CD24 | 1645 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.456 | 25676692
|
CD24 | 1645 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.24 | 0.456 | 26259570
|
DHCR7 | 2860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
DHCR7 | 2860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0064 | 26259570
|
FASN | 3594 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 25676692
|
FASN | 3594 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0074 | 26259570
|
HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692
|
HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692
|
HMGCS1 | 5007 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0074 | 26259570
|
IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692
|
IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692
|
IGFBP3 | 5472 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.24 | 0.0095 | 26259570
|
MIR100 | 31487 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 25676692
|
MIR1269B | 41787 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
MIR1269B | 41787 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
MIR15B | 31544 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0085 | 25676692
|
MIR210 | 31587 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
MIR215 | 31592 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 25676692
|
MIR22 | 31599 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
MVD | 7529 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 25676692
|
MVD | 7529 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0042 | 26259570
|
NDGG1 | NA | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692
|
NDGG1 | NA | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692
|
ODC1 | 8109 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
ODC1 | 8109 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0021 | 26259570
|
TGFB1 | 11766 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692
|
TGFB1 | 11766 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692
|
CD24 | 1645 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.456 | 25676692
|
DHCR7 | 2860 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
FASN | 3594 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 25676692
|
HMGCS1 | 5007 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692
|
IGFBP3 | 5472 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692
|
MIR100 | 31487 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 25676692
|
MIR1269A | 35337 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
MIR1269B | 41787 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692
|
MIR15B | 31544 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0085 | 25676692
|
MIR210 | 31587 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692
|
MIR215 | 31592 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 25676692
|
MIR22 | 31599 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
MVD | 7529 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 25676692
|
NDGG1 | NA | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692
|
ODC1 | 8109 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692
|
TGFB1 | 11766 | HTM/LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692
|
NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 34405006
|
NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.5461 | 27783993
|
NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 25676692
|
NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.5461 | 22194816
|
POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 27773936
|
POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 34405006
|
POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.6448 | 27783993
|
POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 25676692
|
POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.6448 | 22194816
|
SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 27773936
|
SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 34405006
|
SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.5695 | 27783993
|
SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.5695 | 22194816
|
THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.0371 | 27783993
|
THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0371 | 25676692
|
THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.2 | 0.0371 | 22194816
|
ABCB5 | 46 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0085 | 22194816
|
ABCC1 | 51 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0212 | 22194816
|
ALDH1A2 | 15472 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | ALDEFLUOR assay | NA | 0.12 | 0.0117 | 34405006
|
CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 1 | 22194816
|
CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by FACs | NA | 0.12 | 1 | 25676692
|
CTNNB1 | 2514 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0647 | 22194816
|
GRN | 4601 | LTM | Hepatic Cancer | Carcinoma | Hep3B | NA | FACs followed by CFA | NA | 0.12 | 0.0032 | 22194816
|
A1CF | 24086 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
ABCA5 | 35 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ABCA9 | 39 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ABCC6P1 | 33352 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ABHD3 | 18718 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ABLIM3 | 29132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ACSL4 | 3571 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
ACTR6 | 24025 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ADAMTS6 | 222 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ADCY10 | 21285 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ADPRM | 30925 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AFDN-DT | 21236 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AFP | 317 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
AGAP5 | 23467 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AGAP6 | 23466 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AGR2 | 328 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
AHSA2P | 20437 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AK9 | 33814 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AKR1D1 | 388 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ALAD | 395 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ALDOC | 418 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
ALG10B | 31088 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ALPL | 438 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
AMDHD1 | 28577 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
AMPD3 | 470 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ANGPTL4 | 16039 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ANKRD49 | 25970 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ANO1 | 21625 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
ANXA3 | 541 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 26259570
|
ANXA4 | 542 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
ARG1 | 663 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ARG2 | 664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
ARGLU1 | 25482 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ARHGEF16 | 15515 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
ARHGEF25 | 30275 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ARMCX3 | 24065 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ATP2B2 | 815 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ATP6V1B1 | 853 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
B3GNT5 | 15684 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
BAIAP2L2 | 26203 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
BBIP1 | 28093 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
BCAS1 | 974 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
BCL6 | 1001 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
BEX1 | 1036 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
BMF | 24132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
BOP1 | 15519 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
BVES | 1152 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
C14ORF132 | 20346 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
C1D | 29911 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
C1R | 1246 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
C1S | 1247 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
C2ORF88 | 28191 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
C3 | 1318 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
C4ORF33 | 27025 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
C8ORF4 | 25646 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CA9 | 1383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CAD | 1424 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
CALCOCO1 | 29306 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CAMK1 | 1459 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
CAV1 | 1527 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 26259570
|
CAV2 | 1528 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
CBWD3 | 18519 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CCDC198 | 20189 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CCDC80 | 30649 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CCDC92 | 29563 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CCT6P1 | 33094 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CD58 | 1688 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CDH12 | 1751 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CDK14 | 8883 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CDKN2B-AS1 | 34341 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CFAP251 | 28506 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CFAP44 | 25631 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CFI | 5394 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CHP2 | 24927 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
CITED2 | 1987 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
CLDN4 | 2046 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
CLDN5 | 2047 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
CLHC1 | 26453 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CLIP3 | 24314 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CLK1 | 2068 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CNTD1 | 26847 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CNTNAP1 | 8011 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
COL6A2 | 2212 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CPM | 2311 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
CREB3L3 | 18855 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CRLS1 | 16148 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CRYGS | 2417 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CSAD | 18966 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CSRP1 | 2469 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CSRP2 | 2470 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CTSZ | 2547 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CUTC | 24271 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
CUX2 | 19347 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CXCL12 | 10672 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CYFIP2 | 13760 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CYGB | 16505 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
CYP27C1 | 33480 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
CYP3A7 | 2640 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
CYP4V2 | 2640 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
CYTH1 | 23198 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
DAPK1 | 2674 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
DENND10 | 31793 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
DEPP1 | 23355 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
DFNA5 | 2674 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
DFNB59 | 2810 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
DLX6-AS1 | 37151 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
DNAH11 | 2942 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
DNAJC28 | 1297 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
DPYD | 3012 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
DSE | 21144 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
DTNA | 3057 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
DUS3L | 26920 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
DUSP1 | 3064 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
DUSP10 | 3065 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
EEF1A2 | 3192 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
EEF2KMT | 32221 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
EFEMP1 | 3218 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
EFNA1 | 3221 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
EGFL8 | 13944 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
EGLN3 | 14661 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
EID3 | 32961 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ELOVL2 | 14416 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
ELOVL7 | 26292 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
EML6 | 35412 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ENPP1 | 3356 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
EPHA1 | 3385 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
EPO | 3415 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ESYT3 | 24295 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ETAA1 | 24648 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ETFRF1 | 27052 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ETV4 | 3493 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25676692
|
FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25676692
|
FADS2 | 3575 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
FAM13B | 1335 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FAM200B | 27740 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FAM214A | 25609 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
FAM229B | 33858 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
FAM43A | 26888 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FAM76A | 28530 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FBXL21P | 13600 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FBXO8 | 13587 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FBXW9 | 28136 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25676692
|
FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25676692
|
FDFT1 | 3629 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
FGF11 | 3667 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
FGF12 | 3668 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
FHOD3 | 26178 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
FLJ22536 | NA | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FLVCR2 | 20105 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
FSCN1 | 11148 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 26259570
|
FXYD3 | 4027 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
FYB2 | 27295 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
FZD4 | 4042 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
G0S2 | 30229 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
GABARAPL1 | 4068 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
GC | 4187 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
GCNT4 | 17973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
GFRA3 | 4245 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
GHR | 4263 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
GJC2 | 17494 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
GOLGA8IP | 26660 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
GPR183 | 3128 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
GPX2 | 4554 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
GRAMD2B | 24911 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
GRIK4 | 4582 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
GSAP | 28042 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
GSDMB | 23690 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
GUSBP1 | 13670 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
H19 | 4713 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25676692
|
HABP2 | 4798 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
HAVCR1 | 17866 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
HCAR2 | 24827 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
HES6 | 18254 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
HGH1 | 24161 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
HHLA2 | 4905 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HIF3A | 15825 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HIST1H1E | 4718 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HLF | 4977 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HMGCR | 5006 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
HMGCS2 | 5008 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
HPD | 5147 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
HSPB8 | 30171 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HTR2B | 5294 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HTRA4 | 26909 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HULC | 34232 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
HYAL1 | 5320 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
ID1 | 5360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
ID2 | 5361 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
ID4 | 5363 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
IFI6 | 4054 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
IFIT2 | 5409 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
IFTAP | 25142 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
IGF2 | 5466 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
IGF2BP2-AS1 | 32674 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
IGFBP1 | 5469 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
IGLL3P | 5872 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
IKBIP | 26430 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
IL1R1 | 5993 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
IL8 | 6025 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 26259570
|
INHA | 6065 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
INHBB | 6067 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
INSIG2 | 20452 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
IRAK4 | 17967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ITGA2 | 6137 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 26259570
|
ITGB3BP | 6157 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ITPKA | 6178 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
JAK2 | 6192 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
KBTBD11 | 29104 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
KCNAB2 | 6229 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
KCNF1 | 6246 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
KCNJ5 | 6266 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
KCNT2 | 18866 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
KIF5C | 6325 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
KISS1R | 4510 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
KLF6 | 2235 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
KLHDC2 | 20231 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
KMO | 6381 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
KMT2E-AS1 | 40845 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
KNG1 | 6383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
L3HYPDH | 20488 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
L3MBTL1 | 15905 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LAMC2 | 6493 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
LAMC3 | 6494 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
LARP6 | 24012 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LAS1L | 25726 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
LFNG | 6560 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
LGALS1 | 6561 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
LGALS14 | 30054 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LGI4 | 18712 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LIG4 | 6601 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LINC00261 | 16189 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LINC02210 | 26327 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LINC02249 | 32351 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LINC-PINT | 26885 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LIPC | 6619 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
LOX | 6664 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
LOXL4 | 17171 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LPIN2 | 14450 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LRAT | 6685 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
LRP5L | 25323 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LRRC37A3 | 32427 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
LRRC37BP1 | 25390 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LRRC49 | 25965 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
LY6E | 6727 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
MAMDC4 | 24083 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MAP3K6 | 6858 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
MAP3K8 | 6860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
MBD4 | 6919 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
MBL2 | 6922 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MCAM | 6934 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
MCC | 6935 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
MCM7 | 6950 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
MCOLN3 | 13358 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
MEP1A | 7015 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
MIPOL1 | 21460 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
MIR149 | 31536 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
MIR149 | 31536 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
MIR181C | 31552 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
MIR181C | 31552 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
MIR199A1 | 31571 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25676692
|
MIR199A1 | 31571 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25676692
|
MIR199B | 31573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
MIR199B | 31573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
MIR22HG | 28219 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MIR29C | 31621 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
MIR29C | 31621 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
MIR338 | 31775 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
MIR338 | 31775 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
MIR375 | 31868 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
MIR375 | 31868 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
MIR378A | 31871 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
MIR378A | 31871 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25676692
|
MIR378D1 | 41550 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
MIR378D1 | 41550 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
MIR450B | 33642 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
MIR450B | 33642 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
MIR760 | 33666 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
MIR760 | 33666 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25676692
|
MKKS | 7108 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MMD | 7153 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
MOXD1 | 21063 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MPZL2 | 3496 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
MST1 | 7380 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
MST1L | 7390 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MST1P2 | 7383 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MTERFD3 | 30779 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
MTSS1 | 20443 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
MUC13 | 7511 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
MYBBP1A | 7546 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
MYH3 | 7573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
MYLK3 | 29826 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
N4BP2L2-IT2 | 25038 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
NAALADL1 | 23536 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
NAP1L5 | 19968 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
NAPB | 15751 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
NAPRT | 30450 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
NAT1 | 7645 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
NAV2 | 15997 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
NAV3 | 15998 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
NCR3LG1 | 42400 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
NDRG1 | 7679 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
NEIL2 | 18956 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
NKAIN1 | 25743 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
NKD2 | 17046 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
NLE1 | 19889 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
NLRP8 | 22940 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
NOL6 | 19910 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
NOP16 | 26934 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
NOX4 | 7891 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
NPC1L1 | 7898 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
NQO1 | 2874 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
NR1H4 | 7967 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
NTN1 | 8029 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
NTN4 | 13658 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
NUAK1 | 14311 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
NYNRIN | 20165 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
OAS1 | 8086 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
ORMDL3 | 16038 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
OVGP1 | 8524 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
P3H2 | 19317 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PABPC1L | 15797 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PANX2 | 8600 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PAQR6 | 30132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PCDH17 | 14267 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PCDHB16 | 14546 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PCMTD2 | 15882 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PDCD11 | 13408 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PDE4C | 8782 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PDE5A | 8784 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
PDGFRA | 8803 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PDZK1 | 8821 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PEX2 | 9717 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PFAS | 8863 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
PFDN4 | 8868 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PFN1P2 | 24298 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PGAM5 | 28763 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PHKA2 | 8926 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PHLDB2 | 29573 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
PID1 | 26084 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PIEZO2 | 26270 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PIK3IP1 | 24942 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PITX1 | 9004 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PKLR | 9020 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PLA1A | 17661 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PLA2G4C | 9037 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
PLCXD3 | 31822 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PLEKHB1 | 19079 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PLIN2 | 248 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25676692
|
PLOD2 | 9082 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
PLSCR4 | 16497 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
PMFBP1 | 17728 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
POLR1E | 17631 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
POLR3D | 1080 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
POP1 | 30129 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
PPARGC1A | 9237 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PPFIBP2 | 9250 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
PPP1R1C | 14940 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PRG2 | 9362 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PRICKLE2 | 20340 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PRKAB2 | 9379 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PRLR | 9446 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
PRODH | 9453 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
PRR7 | 28130 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PTHLH | 9607 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
PTP4A3 | 9636 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
PTPRH | 9672 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
PTPRM | 9675 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
PUS1 | 15508 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
RALB | 9840 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
RALGPS1 | 16851 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
RARB | 9865 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
RASL11A | 23802 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
RASSF5 | 17609 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
RBM43 | 24790 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
RECQL4 | 9949 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
RGL4 | 31911 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
RHOB | 668 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
RIN1 | 18749 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
RNF217 | 21487 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
RNF7 | 10070 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ROBO2 | 10250 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
RRP12 | 29100 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
RRP9 | 16829 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
RTN4R | 18601 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
RWDD2A | 21385 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
RWDD3 | 21393 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
S100A11 | 10488 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
SCARNA9 | 32566 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SCN2A | 10588 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SCRIB | 30377 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SECTM1 | 10707 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
SELENBP1 | 10719 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
SEMA3F | 10728 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SEMA7A | 10741 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
SEPHS2 | 19686 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SEPTIN7P2 | 32339 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SERPINA5 | 8723 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SERPINF1 | 8824 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25676692
|
SERPING1 | 1228 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25676692
|
SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25676692
|
SFN | 10773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
SH2D5 | 28819 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
SLC1A3 | 10941 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
SLC22A15 | 20301 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SLC22A23 | 21106 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SLC25A47 | 20115 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SLC2A12 | 18067 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SLC2A2 | 11006 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SLC30A10 | 25355 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SLC39A4 | 17129 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25676692
|
SLC43A2 | 23087 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
SLC5A11 | 23091 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
SLC6A12 | 11045 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
SLC6A14 | 11047 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SLC6A20 | 30927 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SLC7A5 | 11063 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
SLCO4A1 | 10953 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
SMAD7 | 6773 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
SMIM24 | 37244 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SNAP25 | 11132 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SNHG6 | 32965 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SOCS2 | 19382 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 26259570
|
SORL1 | 11185 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SP8 | 19196 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SPACA6 | 27113 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SPDYE1 | 16408 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SPTBN2 | 11276 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SQLE | 11279 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
SREBF2 | 11290 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
SSTR5 | 11334 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
ST20 | 33520 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ST3GAL6 | 18080 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ST6GAL1 | 10860 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
STARD8 | 19161 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
STBD1 | 24854 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
STK33 | 14568 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SUSD1 | 25413 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
SYBU | 26011 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
SYNE3 | 19861 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
SYNE4 | 26703 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
TANC2 | 30212 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
TCOF1 | 11654 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
TCP11L2 | 28627 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
TEDC1 | 20127 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
TF | 11740 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
TFF3 | 11757 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 26259570
|
TGFB2 | 11768 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 26259570
|
TGFBI | 11771 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
THAP6 | 23189 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
THBS1 | 11785 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
THBS4 | 11788 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
THSD4 | 25835 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
TIAM2 | 11806 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TINAGL1 | 19168 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
TKT | 11834 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 26259570
|
TM2D3 | 24128 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TM4SF4 | 11856 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
TMED10P1 | 30754 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TMEM263 | 28281 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TMEM51 | 25488 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TMEM82 | 32350 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
TMEM97 | 28106 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
TNFAIP3 | 11896 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 26259570
|
TNFSF4 | 11934 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TNNT1 | 11948 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25676692
|
TNS1 | 11973 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
TONSL | 7801 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
TOR4A | 25981 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
TP53INP1 | 18022 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
TPM1 | 12010 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 26259570
|
TPRKB | 24259 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
TRAPPC9 | 30832 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25676692
|
TRIM15 | 16284 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
TRIM31 | 16289 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
TRIM58 | 24150 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
TTC39C | 26595 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
TXNDC9 | 24110 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
UBD | 18795 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
UCA1 | 37126 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
UGT1A1 | 12530 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
UGT1A6 | 12538 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 26259570
|
UGT2B10 | 12544 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
UNC80 | 26582 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
USP49 | 20078 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
VAV3 | 12659 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
VEPH1 | 25735 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
VN1R2 | 19872 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
VNN3 | 16431 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
WDR5B | 17826 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
WDR72 | 26790 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
WDSUB1 | 26697 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
WHAMMP2 | 32360 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
WSB2 | 19222 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
XRCC3 | 12830 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 26259570
|
YAF2 | 17363 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ZBTB18 | 13030 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZCCHC9 | 25424 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZDHHC13 | 18413 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ZDHHC2 | 18469 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZIC4 | 20393 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF124 | 12907 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF140 | 12925 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
ZNF189 | 12980 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ZNF212 | 13004 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 26259570
|
ZNF277 | 13070 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF287 | 13502 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF302 | 13848 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ZNF331 | 15489 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ZNF334 | 15806 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF354C | 16736 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF432 | 20810 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF614 | 24722 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 26259570
|
ZNF649 | 25741 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 26259570
|
ZNF69 | 13138 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF75D | 13145 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|
ZNF814 | 33258 | HTM | Hepatic Cancer | Carcinoma | Hep3B | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 26259570
|